Literature DB >> 8987921

Hysterectomy after endometrial ablation.

J B Unger1, G R Meeks.   

Abstract

OBJECTIVES: Our purpose was to determine the number of women undergoing hysterectomy after endometrial ablation and the indications for the subsequent surgery. STUDY
DESIGN: Forty-two premenopausal women, who had severe menorrhagia associated with a clinically normal examination result, underwent rollerball endometrial ablation between November 1990 and December 1991. Thirty-seven women whom we gave ongoing care were evaluated by chart review. Four women who received care elsewhere were interviewed by telephone. One woman was lost to follow-up. Patients were followed up a minimum of 4 years. Age, parity, operating time, endometrial preparation, preablation sterilization, and preablation dysmenorrhea were assessed in regard to subsequent hysterectomy. Patient satisfaction was assessed at 24 months. Life-table analysis was performed to determine cumulative probability of hysterectomy.
RESULTS: Fourteen of the 41 women (34%) underwent hysterectomy within 5 years after rollerball endometrial ablation. Continued abnormal menstrual bleeding and menstrual pain were significantly associated with subsequent hysterectomy. Eleven of the 14 cases of hysterectomy were associated with gross abnormality such as myomas, adenomyosis, endometriosis, and chronic hematosalpinx. A linear relationship between hysterectomy and time was noted.
CONCLUSION: On the basis of our findings one third of women undergoing rollerball endometrial ablation for menorrhagia can expect to have a hysterectomy within 5 years. If the linear relationship noted during the first 5 years is extrapolated, theoretically, all women may need hysterectomy by 13 years. Most patients undergo hysterectomy because of significant pelvic abnormality. Further studies with longterm follow-up are needed to define the role of endometrial ablation for menorrhagia.

Entities:  

Mesh:

Year:  1996        PMID: 8987921     DOI: 10.1016/s0002-9378(96)70086-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy.

Authors:  F A Taran; E A Stewart; S Brucker
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

Review 2.  Dysfunctional uterine bleeding.

Authors:  B H Chen; L C Giudice
Journal:  West J Med       Date:  1998-11

3.  Comparison of the regenerative effects of bone marrow/adipose-derived stem cells in the Asherman model following local or systemic administration.

Authors:  Farhad Monsef; Tayebe Artimani; Zohreh Alizadeh; Mahdi Ramazani; Ghasem Solgi; Mahnaz Yavangi; Sara Soleimani Asl
Journal:  J Assist Reprod Genet       Date:  2020-06-14       Impact factor: 3.412

4.  Combining myoma coagulation with endometrial ablation/resection reduces subsequent surgery rates.

Authors:  H A Goldfarb
Journal:  JSLS       Date:  1999 Oct-Dec       Impact factor: 2.172

5.  Systemic administration of bone marrow-derived cells leads to better uterine engraftment than use of uterine-derived cells or local injection.

Authors:  Ying Liu; Reshef Tal; Nicola Pluchino; Ramanaiah Mamillapalli; Hugh S Taylor
Journal:  J Cell Mol Med       Date:  2017-08-07       Impact factor: 5.310

6.  Long-term results in the treatment of menorrhagia and hypermenorrhea with a thermal balloon endometrial ablation technique.

Authors:  L Mettler
Journal:  JSLS       Date:  2002 Oct-Dec       Impact factor: 2.172

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.